Mark Andrew Wilson, SVP & General Counsel at NEKTAR THERAPEUTICS (NKTR), sold 13,128 shares at $13.16 ($173K) on 2021-11-16, disclosed to the SEC on 2021-11-17.
Open-market sale of $173k NKTR by SVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.16 | 6,564 | $86K | 50.0% |
| 2 | $13.16 | 6,564 | $86K | 50.0% |
| Total | $13.16 avg | 13,128 | $173K | 100% |
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |